US FDA recommends healthcare providers switch from Getinge's heart devices
May 8 (Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge's GETIb.ST heart devices as they continued to have safety and quality concerns. (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsEurope Research Roundup: Akzo Nobel, Handelsbanken, RS Group
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix
Sweden's Getinge Q3 organic sales rise 2.1%
Brief: Getinge Q3 Adjusted EBITA SEK 1,278 Million